1. IBRUTINIB MONOTHERAPY PRODUCES LONG‐TERM DISEASE CONTROL IN PREVIOUSLY TREATED WALDENSTROM'S MACROGLOBULINEMIA. FINAL REPORT OF THE PIVOTAL TRIAL (NCT01614821). (12th June 2019) Authors: Treon, S.P.; Meid, K.; Gustine, J.; Yang, G.; Xu, L.; Patterson, C.J.; Ghobrial, I.; Laubach, J.P.; Hunter, Z.R.; Dubeau, T.; Palomba, L.; Advani, R.; Castillo, J.J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗